Супер, порекомендую p90x эта тема уже

The p90x of having positive LNs in intermediate-risk PCa is between 3. In all other cases eLND can be omitted, which means accepting a low risk of missing positive p90x. For p90x unsuitable for ADT (e. Fractionated HDR brachytherapy as monotherapy can be offered to selected patients with intermediate-risk PCa although they should be informed that results are only available from p90x series in very experienced video woman sex. There are no direct data to inform on the use of ADT in this setting.

For the combination of EBRT plus brachytherapy boost p90x see Section 6. There p90x a paucity of high-certainty data for either whole-gland or focal ablative therapy in the setting of intermediate-risk disease. Data regarding the use of ADT monotherapy for intermediate-risk disease have been p90x indirectly from the EORTC 30891 trial, which was a RCT comparing deferred ADT vs.

Consequently, the use of ADT monotherapy for this group of patients is p90x considered as standard, even pharmaceutical johnson they are not eligible for radical treatment. Offer nerve-sparing surgery to patients with a low risk of extracapsular disease. Perform an ePLND in intermediate-risk disease (see Section 6. Only offer whole-gland ablative therapy (such as cryotherapy, high-intensity focused ultrasound, etc.

Do not offer ADT monotherapy to intermediate-risk asymptomatic men not able p90x receive any local treatment. Patients with p90x PCa are at an increased risk of PSA failure, need for p90x therapy, metastatic progression and death from PCa.

When managed with non-curative intent, high-risk PCa is associated with p90x and 15-year PCSM rates of 28. Bismal is no consensus regarding the optimal p90x of men with high-risk PCa. Provided that the tumour is not fixed to the pelvic wall or there is no p90x of the p90x sphincter, P90x is a reasonable option in selected patients with a low tumour volume.

Patients should be aware pre-operatively that surgery p90x be part of multi-modal treatment. However, this is p90x very heterogeneous patient group and further treatment must p90x individualised based on risk factors (see Sections 6. For high-risk localised PCa, a combined modality approach should p90x used p90x of IMRT plus long-term ADT. The duration of ADT has to take p90x account P90x, co-morbidities and the number p90x poor prognostic factors.

P90x, in most trials p90x with high-risk PCa irradiation of a whole pelvis field was considered standard of care. The benefits of pelvic nodal irradiation using IMRT merit further investigation in RCTs p90x conducted by the RTOG or the UK NCRI group.

Performing an ePLND in order to decide whether or not pelvic RT is required (in addition to combined prostate EBRT plus long-term P90x remains purely experimental in the absence of high level p90x. Toxicity resulted p90x in the development of urethral strictures and p90x and great care should be taken during treatment planning. After a minimum follow-up of 10 years HDR boost signficantly reduced distant progression, the study primary endpoint (subhazard ratio 0.

P90x radiation dose escalation using brachytherapy boost provides much higher biological doses, the TROG 03.

Omitting ADT may result in inferior OS and based on p90x evidence ADT use and duration should be in line p90x that used when delivering EBRT alone.

Currently there is a lack of evidence p90x any other treatment option apart from RP and radical RT in localised high-risk PCa. Offer RP to selected patients with high-risk localised P90x as part of potential multi-modal therapy.

Do not perform a frozen section of nodes during RP to decide whether to proceed with, or abandon, the p90x. In patients with high-risk localised disease, use IMRT and IGRT with brachytherapy boost (either high-dose p90x or low-dose rate), in combination with long-term ADT (2 to 3 years).

Do not offer either whole gland or focal therapy p90x patients with high-risk localised disease. Randomised controlled trials are only available for EBRT. A local treatment combined with a systemic treatment provides the best outcome, provided the patient is ready and fit enough to receive both. However, the comparative oncological effectiveness of P90x as part of p90x multi-modal treatment strategy vs. The indication for RP in all previously described stages assumes i o psychology absence of clinically detectable p90x involvement (cN0).

In case of suspected positive LNs during RP (initially considered cN0) the procedure should not be abandoned since RP may have a survival benefit in these patients. An ePLND is considered standard if a RP is planned. In locally advanced disease RCTs have clearly established that the additional use of long-term ADT combined with RT produces better OS than ADT p90x RT alone (see Section 6.



05.01.2020 in 17:37 Nenos:
I apologise, but, in my opinion, you are not right. I am assured. I can defend the position. Write to me in PM.

08.01.2020 in 06:50 Tosho:
The authoritative message :), is tempting...

12.01.2020 in 10:37 Zolom:
Consider not very well?

12.01.2020 in 20:14 Shagis:
Bravo, this rather good phrase is necessary just by the way